Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

German Registry Evaluates Systemic Psoriasis Treatments

Michele B. Kaufman, PharmD, BCGP  |  November 4, 2015

The German Psoriasis Registry, PsoBest, found conventional systemic and biologic drugs for psoriasis demonstrated relative safety from serious adverse events in patients between January 2008–December 2012…

Filed under:Biologics/DMARDsDrug Updates Tagged with:BiologicsGermanyMethotrexatePsoriasis

RA Patients on DMARDs Have Higher Risk of Infection

Richard Quinn  |  November 3, 2015

Preventing infection in patients with RA should be a consideration for rheumatologists prescribing disease modifying anti-rheumatic drugs after a Swedish study found patients on these therapies have a 6.1% risk of developing serious infection.

Filed under:ConditionsRheumatoid Arthritis

Tofacitinib on Hold for Psoriasis, Plus Anti-TNFs Top FDA List for Adverse Events

Michele B. Kaufman, PharmD, BCGP  |  October 28, 2015

The FDA is asking for more safety analysis before approving tofacitinib to treat psoriasis. Also, adalimumab and etanercept received the greatest number of adverse and serious adverse events reported to the FDA in 2014…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabadverse eventsAnti-TNFetanerceptFDAFood and Drug AdministrationInstitute for Safe Medication Practicesplaque psoriasisTofacitinibtofacitinib citrate

Even Doctors & Nurses Don’t Always Have Healthy Lifestyles

Lisa Rapaport  |  October 22, 2015

NEW YORK (Reuters Health)—Even doctors and nurses don’t always follow the healthy lifestyle choices they recommend for patients to reduce the risk of medical problems, such as obesity, heart disease and diabetes, a U.S. study suggests. Although rates of these conditions appeared lower among healthcare workers than other people, the diseases were still common. They…

Filed under:Practice SupportProfessional Topics Tagged with:chronic conditionhealth professionalslifestyleObesityphysical activityphysicianquality of life

FDA Warns ‘Don’t Use Tramadol in Children’ & More

Michele B. Kaufman, PharmD, BCGP  |  October 21, 2015

New studies show ABT-494 is an effective alternative to anti-TNF alpha agents, as well as methotrexate, for RA. Also, the FDA issued a warning against using tramadol for young patients due to their increased risk of respiratory side effects…

Filed under:Drug Updates

Celiac Disease in Pediatric Patients

Richard Quinn  |  October 21, 2015

A retrospective study shows that some patients presenting for pediatric rheumatology evaluation test positive for celiac disease—some without showing any gastrointestinal manifestations. Treatment includes a gluten-free diet…

Filed under:ConditionsPractice Support Tagged with:celiac diseasegastrointestinalPediatric RheumatologyPractice Management

Musculoskeletal Ultrasound: A Valuable Tool for Diagnosing Rheumatic Illnesses

Musculoskeletal Ultrasound: A Valuable Tool for Diagnosing Rheumatic Illnesses

Khushboo Sheth, MBBS, & Christopher Scola, MD  |  October 15, 2015

Musculoskeletal (MSK) ultrasound is a valuable imaging modality for the practicing rheumatologist and provides an efficient tool with high diagnostic value in the evaluation of patients with musculoskeletal complaints. The use of MSK ultrasound has evolved in the U.S. due to the emergence of less-expensive, portable ultrasound units, which provide high-quality gray-scale and power Doppler…

Filed under:ConditionsRheumatoid Arthritis Tagged with:ClinicalDiagnosisMSKMusculoskeletal Ultrasoundpatient careRARheumatoid arthritisrheumatologistsrheumatologyTrainingUltrasound

Adalimumab, Tacrolimus Effective for Treating Refractory Ulcerative Colitis

Will Boggs, MD  |  October 15, 2015

NEW YORK (Reuters Health)—The human IgG1 anti-TNF antibody adalimumab is safe and effective for short- and long-term treatment, and the calcineurin inhibitor tacrolimus given short-term brings remission, in patients with refractory ulcerative colitis, according to two new studies in the Journal of Crohn’s and Colitis. In the first study, online Sept. 21, Dr. Tamas Molnar…

Filed under:Biologics/DMARDsConditionsDrug UpdatesOther Rheumatic Conditions Tagged with:adalimumabAnti-TNFtacrolimusulcerative colitis

Rheumatologist Robert H. Shmerling, MD, Volunteers Time for Children Affected by Domestic Violence

Carol Patton  |  October 14, 2015

On any Thursday from 7 p.m. to 8 p.m., you can find Robert H. Shmerling, MD, playing tag, basketball or even roughhousing with a group of children at Second Step, a transitional living program that offers victims of domestic violence in the Boston area a safe place to live and opportunities to go back to…

Filed under:Professional TopicsProfiles Tagged with:CareerChildrenProfilerhuematologistVolunteer

Opinion: Insurance Companies Use Medically and Fiscally Irresponsible Formularies

Bruce Rothschild, MD  |  October 14, 2015

Receipt of an unsolicited communication that a sweepstakes award has been won may con some people (especially, but not limited to, those underprivileged or undereducated as to legalities), but can’t fool all of the people all of the time. The names of the organizations and products involved are often marketing tool inventions, which imply special…

Filed under:EthicsInsuranceLegal UpdatesProfessional Topics Tagged with:formulariesinsuranceLegalrheumatology

  • « Previous Page
  • 1
  • …
  • 228
  • 229
  • 230
  • 231
  • 232
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences